The Europe Cardiac Pacemaker Market would witness market growth of 6.5% CAGR during the forecast period (2018 – 2024). A pacemaker is an electrical device and it is used to treat arrhythmias, which leads to irregular heartbeat. A pacemaker is generally used to help patients suffering from arrhythmias, to lead an active and healthy life style. Implantable cardiac pacemakers have been witnessing significant demand due to growing cases of slow heart rhythm and cardiac failures. Additionally, technological advancements such as development of MRI compatible pacemakers have further driven the growth of the market. Growing prevalence of cardiovascular disorders in developed nations, rapidly growing cases of cardiac disease in underdeveloped nations, supportive government initiatives, and non-government organizations funding are the factors that are driving the growth of the cardiac pacemaker market.
Based on Product, the market is segmented into Implantable Cardiac Pacemakers and External Cardiac Pacemaker. Based on the technology, the market is segmented into Single-Chamber Cardiac Pacemakers, Dual-Chamber Cardiac Pacemakers and Others. Based on End User, the market is segmented into Hospitals; Ambulatory Surgery Centers (ASCs) and Other End User. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.